| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 4,000 | $9.06 | $36,240.00 | -100% | |
| Dec 4, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sell | 3,922 | $9.45 | $37,062.90 | -2.9% | |
| Dec 3, 2018 | Stonehouse Jon P80 | President &CEO | Sale+OE | 80,000 | $9.12 | $729,600.00 | -9.9% | |
| Nov 30, 2018 | Barnes Alane P70 | Senior VP, Chief Legal Officer | Sale+OE | 44,290 | $9.07 | $401,710.30 | -36.2% | |
| Nov 23, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 15,500 | $9.32 | $144,420.00 | -3.6% | |
| Nov 21, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 14,455 | $9.05 | $130,839.55 | -85.5% | |
| Nov 20, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 15,470 | $8.55 | $132,315.44 | -44.0% | |
| Nov 20, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 11,198 | $8.67 | $97,116.61 | -2.6% | |
| Nov 8, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 14,087 | $8.12 | $114,386.77 | -3.3% | |
| Nov 8, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 5,580 | $8.14 | $45,432.00 | -24.5% |